4Lovell-Badge R. The future for stem cell research. Nature, 2001,414(6859): 88-91.
5Kim JH, Auerbach JM, Rodriguez-Gomez JA, et al. Dopamineneurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature, 2002, 418 (6893):50-56.
6Bacigalupo A. Haemopoietic stem cell transplants: the impact of haemorrhagic complications. Blood Rev, 2003,1(Suppl):S6- S10.
7Davies JK, Lowdell MW. New advances in acute graft-versushost disease prophylaxis. Transfus Med, 2003,13(6) : 387-397.
8Mookerjee B, Altomonte V, Vogelsang C. Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus. Bone Marrow Transplant, 1999 ; 24(5):517-520.
9Ferrara JI. The cytokine modulation of acute graft-versus-host disease. Bone Marrow Transplant, 1998,21 (Suppl3) : S13-S15.
10[1]Reiffers J, Labopin M, Sanz M, et al. The source of stem cells does not affect the outcome of patients undergoing autologousstem cell transplantation or acute myeloid leukemia in first re mission. Blood 1996;88(suppl 1) :684a
